跳至主要内容
临床试验/NL-OMON23156
NL-OMON23156
已完成
不适用

A treatment components analysis of a stepped-care, CBT based treatment for adults with tinnitus: a replicated single-case experimental approach

Maastricht University Faculty of Psychology and Neuroscience0 个研究点目标入组 6 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
Maastricht University Faculty of Psychology and Neuroscience
入组人数
6
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Interventional

研究者

发起方
Maastricht University Faculty of Psychology and Neuroscience

入排标准

入选标准

  • In order to be eligible to participate in this study, a person must meet all of the following criteria. That is they must:
  • Be primarily seeking treatment/help for difficulties caused by subjective tinnitus
  • Be at least 18 years of age
  • Have at least moderate tinnitus related distress (i.e. TQ score \> 30\)

排除标准

  • A potential participant who meets any of the following criteria will be excluded from participation in this study:
  • Severe depression or anxiety as measured by Dutch version of DASS\-21\.
  • Any person who discloses current suicidal intent.
  • Currently or undertaken any treatment for tinnitus (e.g. CBT, tinnitus retraining therapy ) within the previous 5 years (including the aforementioned RCT)
  • Potential participant has reported to have commenced or ceased a course of antidepressants \[i.e. selective serotonin re\-uptake inhibitors (SSRIs); selective serotonin and norepinephrine re\-uptake inhibitors (SNRIs); atypical antidepressants, tricyclic antidepressants, or monoamine oxidase inhibitors], antipsychotics \[Aripiprazole (Abilify), Asenapine (Saphris), Brexpiprazole (Rexulti), Cariprazine (Vraylar), Clozapine (Clozaril), Iloperidone (Fanapt), Lurasidone (Latuda), Olanzapine (Zyprexa), Paliperidone (Invega), Quetiapine (Seroquel), Risperidone (Risperdal), Ziprasidone (Geodon), Haloperidol], anxioltytics \[beta blockers, benzodiazepines], Ritalin, hormone replacement therapy, or medication to lower high blood pressure (i.e. thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers, beta blockers, calcium channel blockers, renin inhibitors] within the previous 3 months.
  • Currently receiving psychological or any other kind of therapy addressing psychological, social, emotional, and or behavioural problems
  • Unable to read and write fluently in Dutch
  • Commenced the use of a hearing aid in the previous 3 months
  • Has hearing loss greater than 40dB in one or both ears
  • Having previously participated in a study from this project.

结局指标

主要结局

未指定

相似试验